🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this Phase 1 study is to evaluate the safety, tolera...
Status
Terminated
Location
University of California, San Francisco
Start Date
2015-08-27
Trial ID
NCT02428309
Treatments Being Tested
The hypothesis is that Sirolimus, (Rapamycin (R)) which is currently used i...
Status
Active Not Recruiting
Location
University of Kansas Medical Center
Start Date
2022-07-01
Trial ID
NCT04789070
To evaluate if hyper-fractionated TBI or TMLI followed by Treg/Tcon adoptiv...
Status
Unknown
Location
University of Perugia
Start Date
2014-02
Trial ID
NCT03977103
Treatments Being Tested
The investigational product, named Ovasave (Ova-Treg), is a cell-based ther...
Status
Terminated
Location
Medical University Innsbruck
Start Date
2014-12
Trial ID
NCT02327221
The immune system has offensive and defensive capacities. In bone marrow tr...
Status
Terminated
Location
Katholieke Universiteit Leuven
Start Date
2013-07
Trial ID
NCT01903473
Treatments Being Tested
The purpose of this study is to find out whether the combination of botensi...
Status
Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2025-02-20
Trial ID
NCT06843434
Treatments Being Tested
The neonatal pig islets will be used as donor culturing with our modified c...
Status
Completed
Location
Cell Transplantation and Gene Therapy Institute
Start Date
2013-07
Trial ID
NCT03162237
Treatments Being Tested
The purpose of this study is to investigate the safety and therapeutic effe...
Status
Unknown
Location
Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University
Start Date
2016-10
Trial ID
NCT02932826
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of QEL...
Status
Active Not Recruiting
Location
H. Saint Luc
Start Date
2022-01-21
Trial ID
NCT05234190
Treatments Being Tested
This study is a randomized, placebo-controlled, phase 2a trial to study the...
Status
Active Not Recruiting
Location
Massachusetts General Hospital Neurological Clinical Research Institute
Start Date
2019-08-07
Trial ID
NCT04055623